Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy
NCT03657745
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
Electrical activity in the brain known as "gamma" brainwaves help connect and process information throughout the brain. These gamma waves are diminished in Alzheimer's disease. New research in Alzheimer's disease mouse models shows that exposure to light flickering at the rate of 40 flashes per second or 40Hz increased gamma brainwaves and led to clearing of beta amyloid plaques in the brain, a key abnormality in Alzheimer's disease.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Alzheimer Disease
- Mild Cognitive Impairment
- Dementia
- Cognition Disorders in Old Age
- Cognitive Decline
- Cognitive Deterioration
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 50 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Alzheimer's Light LLC
- Last updated on ClinicalTrials.gov
- August 1, 2024
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Florida · 1
- Andrey Vyshedskiy · Miami, FL
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.